Research Article
Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice
Figure 5
Budesonide attenuated LPS-induced mortality. C57BL/6 mice received a lethal dose of LPS (40 mg/kg, i.t.). The mortality of the animals was monitored every 6 h after LPS administration (). compared with the control group and compared with the ALI group.